818.93
price down icon1.30%   -10.81
 
loading

Lilly Eli Co (LLY) 最新ニュース

pulisher
11:45 AM

Eli Lilly price target lowered to $1,015 from $1,025 at Deutsche Bank - Yahoo Finance

11:45 AM
pulisher
10:30 AM

Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro - Yahoo Finance UK

10:30 AM
pulisher
06:18 AM

Merus annonce ses résultats financiers pour le troisième trimestre 2024 et fait le point sur ses activités - GlobeNewswire Inc.

06:18 AM
pulisher
Nov 01, 2024

Eli Lilly grows Milwaukee-area footprint with $40.8M warehouse acquisition — and more - The Business Journals

Nov 01, 2024
pulisher
Nov 01, 2024

Hims & Hers Health Faces Pressure Ahead of Earnings Amid Eli Lilly's GLP-1 News - Yahoo Finance UK

Nov 01, 2024
pulisher
Nov 01, 2024

Eli Lilly’s Q3 Miss for Mounjaro, Zepbound Highlights Dependency on Wholesalers - BioSpace

Nov 01, 2024
pulisher
Nov 01, 2024

Eli Lilly Stock: Is LLY Stock A Sell After Its Disastrous Third-Quarter Report? - Investor's Business Daily

Nov 01, 2024
pulisher
Nov 01, 2024

Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

ViaNautis signs multi-year collaboration with Eli Lilly and Company - Business Weekly

Nov 01, 2024
pulisher
Oct 31, 2024

Friday Five – Humira humbled, Lilly investors get trick instead of treat, Pfizer seeks to show up Starboard… and more - FirstWord Pharma

Oct 31, 2024
pulisher
Oct 31, 2024

Eli Lilly and the British government partner to provide GLP-1 weight loss medication to people who have obesity - HR Brew

Oct 31, 2024
pulisher
Oct 31, 2024

Lilly’s earnings surprise, investors mull the election, & a spooky ghost story - STAT

Oct 31, 2024
pulisher
Oct 31, 2024

Eli Lilly viewed positively despite Mounjaro, Zepbound disappointmentBoA - Proactive Investors USA

Oct 31, 2024
pulisher
Oct 31, 2024

Eli Lilly Shares Hit Yearly Low After Disappointing Q3 Earnings - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Eli Lilly and Company (NYSE:LLY): Among The 10 Best S&P 500 Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

ELI LILLY AND COMPANY : Jefferies remains its Buy rating - Marketscreener.com

Oct 31, 2024
pulisher
Oct 31, 2024

Eli Lilly core thesis ‘remains intact’ despite Q3 miss, says JPMorgan - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Are Eli Lilly's Lowered Expectations a Reason to Sell? - The Motley Fool

Oct 31, 2024
pulisher
Oct 31, 2024

Eli Lilly and Co (LLY) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Eli Lilly and Co (LLY): A Strategic SWOT Insight into Pharma's Future - Yahoo Finance UK

Oct 31, 2024
pulisher
Oct 31, 2024

Nasdaq edges back from its record as chip companies and Eli Lilly slump - The Decatur Daily

Oct 31, 2024
pulisher
Oct 30, 2024

Stocks hit pause after Nasdaq milestone; Eli Lilly earnings underwhelm Wall St. - The Post and Courier

Oct 30, 2024
pulisher
Oct 30, 2024

Health Care Down as Eli Lilly Slides -- Health Care Roundup - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly & Co. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Stock market today: Nasdaq edges back from its record as chip companies and Eli Lilly slump - Oneonta Daily Star

Oct 30, 2024
pulisher
Oct 30, 2024

Wall Street indexes edge lower Wednesday as Alphabet jumps and Eli Lilly slumps - Greater Milwaukee Today | GMToday.com

Oct 30, 2024
pulisher
Oct 30, 2024

AMD, Eli Lilly slide; Google, Visa rise among Wednesday's afternoon market cap stock movers - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast - Benzinga

Oct 30, 2024
pulisher
Oct 30, 2024

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint? - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed - CNBC

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly’s third quarter earnings miss and forecast cut lead to sharp stock drop - LPHeraldDispatch.com

Oct 30, 2024
pulisher
Oct 30, 2024

Knockoff weight loss drugs are having a moment. Eli Lilly isn't worried - Yahoo! Voices

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly (LLY) Q3 2024 Earnings Call Transcript - The Motley Fool

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly plans to begin advertising weight-loss drug Zepbound - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly’s slip does not mean the weight loss drug craze is over - Financial Times

Oct 30, 2024
pulisher
Oct 30, 2024

Stock movers: Alphabet, Super Micro, Eli Lilly and more - TheStreet

Oct 30, 2024
pulisher
Oct 30, 2024

Stock market today: Wall Street wavers as Alphabet jumps on Google profits and Eli Lilly slumps - Ottumwacourier

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly had a strong Q3, so why is its stock falling? - Seeking Alpha

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly Earnings: Maintaining Our Fair Value and Long-Term GLP-1 Forecast Despite Weaker Q3 - Morningstar

Oct 30, 2024
pulisher
Oct 30, 2024

Lilly Cuts Outlook After Obesity Drug Sales Post First Miss - Bloomberg

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly's rare sales miss for weight-loss drug sends shares tumbling - Reuters

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly: The Stock Might Have Peaked (NYSE:LLY) - Seeking Alpha

Oct 30, 2024
pulisher
Oct 30, 2024

Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Lilly cuts outlook on surprising weight-loss drug disappointment - Detroit News

Oct 30, 2024
pulisher
Oct 30, 2024

Why Eli Lilly Stock Is Sinking Today - The Motley Fool

Oct 30, 2024
pulisher
Oct 30, 2024

Lilly shares tumble on earnings report that falls short of Wall Street expectations - Inside INdiana Business

Oct 30, 2024
pulisher
Oct 30, 2024

Stock market today: Wall Street churns near records as Alphabet jumps and Eli Lilly slumps - News-Press Now

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly shares tumble as company’s weight-loss drug misses Wall Street sales expectations - The Globe and Mail

Oct 30, 2024
pulisher
Oct 30, 2024

Have Eli Lilly's weight-loss drug gains hit a plateau? - Sherwood News

Oct 30, 2024
pulisher
Oct 30, 2024

Stock market today: Wall Street churns as Alphabet jumps, Eli Lilly tumbles - Ottumwacourier

Oct 30, 2024
pulisher
Oct 30, 2024

Drugmaker Eli Lilly dials back 2024 forecast after 3Q earnings miss - WTHR

Oct 30, 2024
pulisher
Oct 30, 2024

Drugmaker Eli Lilly walks back 2024 forecast after 3Q earnings miss - Bozeman Daily Chronicle

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly stock tumbles on Q3 miss, Zepbound sales fall short - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Lilly shares fall as obesity drug sales miss forecasts - BioPharma Dive

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly tumbles as weight loss sales underwhelm, guidance slashed - Proactive Investors USA

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly shares tumble as Q3 misses estimates, guidance lowered - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

AnaptysBio plunges as Eli Lilly drops co's arthritis drug from pipeline - XM

Oct 30, 2024
pulisher
Oct 30, 2024

Microsoft and Meta, Eli Lilly, US GDP in Q3: 3 Things - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Eli Lilly Shares Tumble After Disappointing Q3 Earnings Report - Lawyer Monthly Magazine

Oct 30, 2024
drug_manufacturers_general NVO
$111.94
price down icon 0.01%
$203.55
price down icon 0.16%
drug_manufacturers_general JNJ
$160.13
price up icon 0.17%
drug_manufacturers_general MRK
$101.88
price down icon 0.43%
drug_manufacturers_general NVS
$109.35
price up icon 0.88%
大文字化:     |  ボリューム (24 時間):